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Abstract ERp29, a novel and ubiquitously expressed endoplas-
mic reticulum (ER) stress-inducible protein, was recently isolated
and cDNA cloned in our laboratory. Using size exclusion
chromatography and chemical cross-linking we have assessed the
oligomerization properties of ERp29. Purified ERp29 in solution
as well as in rat hepatoma cells self-associates predominantly
into homodimers. Labeling of the cells with [35S]methionine with
subsequent cross-linking and immunoprecipitation showed that
ERp29 interacts with a number of ER proteins, one of which was
previously identified as BiP/GRP78. Secondary structure
prediction and fold recognition methods indicate that the native
conformation of ERp29 resembles the thioredoxin fold, a
structural motif characteristic of a number of enzymes with the
redox function, including protein disulfide isomerase (with which
ERp29 shares limited sequence similarity). Dimerization of the
protein is suggested to be advantageous for the protein binding
potential of ERp29.
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1. Introduction
Cells respond to a variety of environmental stresses includ-
ing physical (e.g. heat) or chemical (e.g. heavy metals, organic
solvents) impacts by increased transcription of genes encoding
so called heat shock or stress proteins. It is widely assumed
that the common cell damaging mechanism for cellular stress
factors is an overaccumulation of malfolded, denatured or
aggregated proteins in the cytoplasm and luminal compart-
ment of the endoplasmic reticulum (ER) [1,2]. The protective
action of stress proteins under these conditions is accom-
plished by binding to denatured or aggregated cellular pro-
teins thereby facilitating their refolding. Many stress proteins
are constitutively expressed and function as molecular chap-
erones, i.e. assist in folding and block aggregation of nascent
polypeptide chains by preventing incorrect intra- and intermo-
lecular interactions. Other folding enzymes, such as protein
disul¢de isomerase (PDI) and peptidylprolyl isomerase, are
also involved in maturation of proteins. PDI is of particular
importance for protein folding in the ER where it catalyzes
the formation and isomerization of disul¢de bonds [3,4] and it
has also been proposed to function as a molecular chaperone
[5^7].
Recently a novel ER stress-inducible protein, ERp29, with a
limited similarity to the eukaryotic protein disul¢de isomer-
ases was isolated from the rat liver and cDNA cloned in our
laboratory [8,9] and by others [10]. The ERp29 gene was
found to be ubiquitously expressed and was activated in re-
sponse to ER stress, i.e. accumulation of transport-incompe-
tent, misfolded and/or underglycosylated secretory proteins.
The ERp29 precursor is processed by a signal peptidase pro-
ducing a mature polypeptide with a predicted molecular mass
of 24.5 kDa, which is targeted to the luminal compartment of
ER.
Our preliminary results [8] indicate that ERp29 co-immu-
noprecipitates with BiP/GRP78, an abundant ER-resident
molecular chaperone, and moreover this association is en-
hanced by tunicamycin, a potent agent causing ER stress.
Typically many luminal stress proteins/chaperones are found
in vivo in such transient heteropolymeric complexes with mis-
folded proteins and with each other. Some of them may also
form stable homooligomers [11^13].
In the present report we utilized size exclusion chromatog-
raphy and chemical cross-linking to study oligomerization and
protein binding properties of ERp29 in vitro and in intact
cells.
2. Materials and methods
2.1. Protein expression and puri¢cation
His6-tagged ERp29 cDNA was expressed in Escherichia coli as de-
scribed earlier [8]. Brie£y, a coding region of ERp29 cDNA (nucleo-
tides 44^826) excluding the leader sequence was subcloned into the
pQE30 expression vector (Qiagen) that adds six histidines to the N-
terminus of the protein. Recombinant ERp29 was expressed in E. coli
strain JM109 and large amounts of the protein were puri¢ed under
non-denaturing conditions on Ni-NTA-agarose a⁄nity column ac-
cording to the manufacturer’s recommendations (Qiagen).
2.2. Size exclusion chromatography
For size exclusion chromatography, Ultrogel AC44 (Pharmacia-
LKB) was equilibrated in NaCl/Pi (8 mM NaH2PO4, 1.5 mM
KH2PO4, 2.7 mM KCl, 300 mM NaCl, pH 7.4). The column was
calibrated by bovine serum albumin (68 kDa), ovalbumin (47 kDa)
and chemotrypsinogen (27 kDa). The void volume was monitored in
each run by dextran blue (2000 kDa). Recombinant ERp29 (0.5 mg)
was applied in a volume of 500 Wl with indicated supplements. The
protein was eluted by NaCl/Pi with the same additives at a £ow rate
of 8 ml/h and 1.4 ml fractions were collected. The elution was moni-
tored by absorbance at 280 nm.
2.3. Electrophoresis and Western blot
Denaturing SDS-PAGE was carried out according to Laemmli [14].
Protein bands were detected with Coomassie brilliant blue R-250.
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For immunoblot analysis, the electrophoretically separated proteins
were transferred to a nitrocellulose membrane and probed with poly-
clonal antibodies raised against recombinant ERp29 as described ear-
lier [8]. Immunoreactive bands were visualized by enhanced chem-
iluminescence according to the manufacturer’s speci¢cations
(Amersham).
2.4. Chemical cross-linking
For cross-linking in solution, ERp29 was incubated in 40 mM
HEPES, 0.2 M NaCl, pH 7.4 with various concentrations of a
water-soluble, uncleavable, homobifunctional cross-linker, BS3
(Pierce), at room temperature for 10 min. The reaction was stopped
by adding 50 mM Tris-HCl, pH 8.0 and the samples were incubated
on ice for 10 min before processing by SDS-PAGE and Coomassie
blue staining. Alternatively ERp29 was cross-linked in the same bu¡er
with glutaraldehyde or dithiobis(succinimidyl propionate) (DSP;
Pierce).
FAO cells (a rat hepatoma line obtained from M. Weiss, Pasteur
Institute, Paris, France) were grown, cross-linked with DSP on ice for
30 min and lysed as described elsewhere [8]. Cell lysates were proc-
essed by SDS-PAGE with subsequent immunoblotting. In another set
of experiments, the cells were labeled for 3 h with [35S]methionine
(Amersham), cross-linked with DSP and lysed. ERp29 was immuno-
precipitated from the cell lysates and immune complexes were ana-
lyzed by SDS-PAGE with subsequent autoradiography.
2.5. Structure predictions
Computer-assisted secondary structure and fold recognition predic-
tions were accomplished using a system of neural networks, PHDsec
[15], and fold recognition method ‘gonnet+predd’ [16] available at
http://www.doe-mbi.ucla.edu/people/frsvr/frsvr.html.
3. Results
3.1. Analysis of puri¢ed ERp29 by size exclusion
chromatography
The mature form of ERp29 was overexpressed in E. coli as
a His-tagged fusion protein and puri¢ed to apparent homo-
geneity as described previously [8]. Size exclusion chromatog-
raphy was used to determine the native molecular mass of the
recombinant protein. The protein was eluted as a sharp peak
in the fractions corresponding to a molecular mass of V55
kDa, whereas no absorbance at 280 nm was registered in the
fractions corresponding to the molecular mass of the mono-
meric form of mature ERp29 (24.5 kDa) (Fig. 1A). This sug-
gests that at the concentration of about 1 mg/ml, ERp29 in
solution exists predominantly as a dimer. Some additional
small peaks eluting earlier than the dimer were also detected,
suggesting that a minor portion of the ERp29 molecules are
assembled in higher-order multimers. In order to assess the
nature of forces stabilizing the oligomeric forms of ERp29,
the protein was incubated with a non-ionic detergent (0.5%
NP-40) or 1 M NaCl and subjected to chromatography. As
evident from the elution pro¢le (Fig. 1B,C) none of these
compounds was able to shift the equilibrium towards the for-
mation of monomeric species or cause dissociation of the
oligomers. Divalent cations such as Ca2 and Mg2 were
also ine¡ective in this sense (results not shown).
3.2. Analysis of multiple species of puri¢ed ERp29 by
cross-linking
To obtain further information on the nature and propor-
tion of ERp29 species in solution, the protein samples were
subjected to cross-linking utilizing the non-cleavable homobi-
functional cross-linker BS3. Cross-linked species were then
resolved by denaturing PAGE and stained with Coomassie
blue. The results presented in Fig. 2A are essentially consis-
tent with the chromatography data. ERp29 molecules at a
concentration of 0.2 mg/ml are cross-linked in a dimer with
a minor fraction assembled in multimers. Interestingly, even in
the non-cross-linked sample (Fig. 2A, lane 1) we observed a
faint band corresponding to the molecular mass of the dimer,
indicating that even under denaturing conditions of SDS-
PAGE, a small amount of the dimer molecules remains intact.
Immunoblotting of the same samples demonstrated immuno-
staining of this 50 kDa band, verifying its identity as a dimer
of ERp29 (results not shown). There are few reports in the
literature where dimeric proteins have been found resistant to
dissociation under the conditions of SDS-PAGE [17,18], ap-
parently due to the very high binding constants of dimeric
interactions [19]. The relatively broad banding pattern of
cross-linked samples and the appearance of the second lower
band apparently attribute to some heterogeneity in the intra-
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Fig. 1. Size exclusion chromatography of puri¢ed ERp29. Recombi-
nant ERp29 (1 mg/ml) was applied on Ultrogel AC44 column and
eluted as described in Section 2. Presented are fractions after the
void volume. The column was calibrated using molecular mass
standards bovine serum albumin (68 kDa), ovalbumin (47 kDa) and
chemotrypsinogen (27 kDa). A: No additions. B: 1 M NaCl. C:
0.5% NP-40.
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molecular cross-linking. Under the same conditions the mo-
lecular mass of ovalbumin remains unchanged, indicating the
speci¢city of cross-linking (Fig. 2B).
The dimeric form of ERp29 could be chased by increasing
concentrations of BS3 to the higher-order oligomers and some
of them were even too large to be resolved by a 12% SDS gel
(Fig. 2A, lanes 2^6). Apparently high concentrations of BS3
caused non-speci¢c extensive cross-linking of dimeric species
of ERp29. A similar trend was seen in the samples with high,
non-physiological concentration of ERp29 (Fig. 2C, lane 3).
SDS-PAGE analysis under non-reducing conditions demon-
strated an identical migration of the ERp29 band (Fig. 2D),
which is a clear indication of a non-disul¢de nature of bonds
linking ERp29 molecules in the dimer. The additional V60
kDa band (Fig. 2D, lane 2) may represent the native oligo-
meric form of a minor bacterial contaminant with disul¢de
bridge(s) (e.g. V28 kDa polypeptide is visible in lane 1 but
absent under non-reducing conditions (lane 2)). As in the case
of size exclusion chromatography, neither high salt nor the
detergent could dissociate the oligomers of ERp29 (Fig. 2A,
lanes 7 and 8). These results were also con¢rmed using other
cross-linkers, such as glutaraldehyde and DSP (data not
shown).
3.3. Chemical cross-linking in the FAO hepatoma cells
In order to examine the oligomerization of ERp29 in intact
cells, FAO hepatoma cells were cross-linked by a cell-perme-
able, thiol-cleavable agent, DSP, lysed and immunoblotted
with anti-ERp29 serum. Under non-reducing conditions of
SDS-PAGE, which maintains complexes linked by DSP in-
tact, the amount of ERp29 oligomers (mostly in the form of
a dimer) was increasing in a dose-dependent manner (Fig.
3A). The appearance of the band migrating closely to the
dimer (Fig. 3A, lanes 2^4) may be interpreted as a result of
the intramolecular cross-linking. No oligomeric complexes
were detected when samples were run under reducing condi-
tions (data not shown). Immunoprecipitation of ERp29 from
the 35S-labeled cells revealed a number of co-immunoprecipi-
tating polypeptides including an appreciable amount of the
non-denatured dimer (Fig. 3B, lane 1). Cross-linking selec-
tively enhances the amount of some co-immunoprecipitated
proteins (e.g. V111 kDa and higher, 78 kDa (previously iden-
ti¢ed as BiP/GRP78, an abundant ER chaperone [8]), 65 kDa
and 50 kDa migrating closely to the dimer) which appear to
be the most probable interacting partners of ERp29 (Fig. 3B,
lanes 2^4). However, the dose-dependent accumulation of the
high molecular species as well as slight increase in the inten-
sity of the dimer band may also re£ect incomplete cleavage of
FEBS 20549 24-7-98
Fig. 3. Cross-linking in FAO cells. A: Cells were treated with: ve-
hicle (Me2SO) (lane 1) or 0.1^1 mM DSP (lanes 2^4). After cross-
linking cells were lysed and processed by non-reducing SDS-PAGE
and immunoblotting using polyclonal ERp29 antibodies. B: Cells
were labeled with [35S]methionine and treated with Me2SO (lane 1)
or 0.1^1 mM DSP (lanes 2^4) before lysis. Lysates from equal num-
bers of cells were immunoprecipitated with ERp29 antibodies and
immune complexes resolved by non-reducing SDS-PAGE with sub-
sequent autoradiography. C: Same as in B, but samples were run
under reducing conditions. m, monomer; d, dimer.
Fig. 2. Cross-linking of puri¢ed ERp29. A: Recombinant ERp29
(0.2 mg/ml) was cross-linked by BS3 and samples were processed by
SDS-PAGE with gels stained with Coomassie blue. Lane 1, control;
lanes 20-6, 0.05^10 mM BS3 ; ERp29 was cross-linked by 0.1 mM
BS3 in the presence of 1 M NaCl (lane 7) and 0.5% NP-40 (lane 8).
B: Ovalbumin (1 mg/ml) was cross-linked under identical conditions
by 0.1 mM BS3 (lane 2). C: Cross-linking of various concentrations
of ERp29 by 0.05 mM BS3 (lane 1, 0.2 mg/ml; lane 2, 2 mg/ml;
lane 3, 10 mg/ml). The same amount of protein (3 Wg) was applied
to each well. D: SDS-PAGE of ERp29 (0.2 mg/ml) under reducing
(lane 1) and non-reducing conditions (lane 2). m, monomer; d,
dimer.
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the DSP-formed complexes by mercaptoethanol. Under non-
reducing conditions these complexes remain uncleaved which
results in the amassing of large oligomers (Fig. 3C, lanes 6^8).
ERp29 appears to be involved in some of them as judged by
the detection of the ERp29-immunoreactive high molecular
mass bands under non-reducing conditions in the cross-linked
samples of FAO cells (Fig. 3A, lanes 2^4). The appearance of
some high molecular mass material even in the non-cross-
linked sample (Fig. 3C, lane 5) under non-reducing conditions
is apparently due to the presence of co-immunoprecipitating
polypeptides containing S-S bonds that are cleaved under re-
ducing conditions.
Thus, cell culture experiments con¢rm that ERp29 exists
mainly as a dimer in intact cells and may also be involved
in some high-order homo- and/or heterocomplexes.
4. Discussion
Our data suggest that at micromolar concentrations in sol-
ution, as well as in intact cells, ERp29 has a well-de¢ned
quaternary structure with two ERp29 molecules assembled
in a homodimer. However, as was shown by the cross-linking
of the recombinant protein, ERp29 at high concentrations
may also form very large aggregates. Considering the abun-
dant accumulation of ERp29 under the stress conditions [8],
we hypothesize that this feature of ERp29 might be essential
for the putative stress defense-related function of ERp29. A
similar functional signi¢cance of oligomerization was ob-
served, for instance, in the binding of cohort protein GrpE
to the bacterial chaperone DnaK [20] or in the ‘superoligo-
merization’ of the small heat shock proteins upon heat shock
[21]. In addition to the homooligomerization features, ERp29
may also interact with other polypeptides, as judged by its co-
immunoprecipitation with a number of ER proteins (Fig. 3B).
One of them was previously identi¢ed as BiP/GRP78 [8],
which raises the intriguing possibility of the putative cooper-
ation of ERp29 with BiP/GRP78 or other chaperones in the
folding/refolding of secretory proteins in the ER.
ERp29 shares limited similarity with the group of protein
disul¢de isomerases from various organisms including plants,
amoebae, a recently discovered protein from Drosophila with
an unknown function [22], and to a lesser extent with the
mammalian PDIs. The latter enzymes have a modular struc-
ture [23] and consist of two homologous thioredoxin domains
(a and aP) containing an active site motif -Cys-Gly-His-Cys-
involved in thiol-disul¢de reactions, two intermediate domains
(b and bP) lacking clearly assigned function and a C-terminal
domain believed to be important for substrate binding [24].
Recent NMR studies on the structure of PDI domains have
shown that, despite the lack of homology between segments a
and b, each of them adopts a global fold very similar to that
of a bacterial thioredoxin and the same structure was pre-
dicted for domains aP and bP [25,26]. Thus, it was suggested
that the PDI molecule essentially consists of linked active and
inactive thioredoxin-like modules, the structure that may have
been evolved by means of partial gene duplication or shu¥ing
of a common thioredoxin ancestral gene [26].
The sequence similarity between ERp29 and PDI (26%
identity over a region of 111 amino acids) is detected in the
N-termini of both proteins (Fig. 4), i.e. between the N-termi-
nal segment of ERp29, comprising amino acids 1^126, and the
a domain of PDI, although the active thioredoxin motif is
absent in ERp29. Interestingly, alignment of ERp29 and
ERp31 (a human analogue of ERp29; unpublished, GenBank
accession number X94910) sequences [10] indicates a very
strong conservation of the N-terminal domains of the human
and rat proteins, thus highlighting its potential functional im-
portance.
When ERp29 sequence was scrutinized by the secondary
structure prediction and fold recognition methods [15,16],
the sequence similarity between the N-domain of ERp29
and the a domain of PDI was augmented by the prediction
of alike K/L-type secondary structure (Fig. 4) and the same
domain of ERp29 was predicted to adopt a thioredoxin-like
global fold similar to the a and b domains of PDI. PDB
database entry 1mek (structure of the a domain of PDI re-
solved by NMR) was the only one with a Z-score signi¢cantly
over the con¢dence threshold needed to con¢rm the fold rec-
ognition (prediction results are available at http://www.doem-
bi.ucla.edu/people/frsvr/preds/18329ERp29/18329ERp29.htm-
l).
The same domain of ERp29 also shares 34% identity over a
stretch of 56 amino acids with the b domain of PDI which
may re£ect the early divergence of ERp29 from the ancestral
PDI gene when the a and b domains were still closely related.
Despite the decrease in sequence similarity between all three
domains (a/b of PDI and N-terminal of ERp29) in the course
of evolution, their thioredoxin-like conformation remained
remarkably intact. A similar conservation of the three-dimen-
sional structures was reported for the distantly related pro-
teins where the amino acid identity level appeared to be al-
most random [27].
Darby et al. [28], analyzing the activity of various PDI
constructs with reshu¥ed domain structures, found that full
catalytic activity requires cooperative involvement of multiple
PDI domains, and b/bP domains are of particular importance.
It was suggested that these internal repeats enhance and di-
versify substrate binding capabilities of PDI as multiple thio-
redoxin modules may provide multiple sites of contact with
substrate proteins [29^31].
Considering the similarities in sequence and conformation
of the a and b domains of PDI and the N-terminal segment of
ERp2 and also the advantages of multidomain composition
with intrinsic homology, we hypothesize that dimerized
ERp29 is essentially a variant of a modular molecule similar
to PDI with two thioredoxin-like subunits placed close to each
other ^ the structure that apparently favors e⁄cient protein
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Fig. 4. Alignment of the N-domain of ERp29 with domain a of
PDI and secondary structure prediction. The output from the fold
recognition program was modi¢ed to highlight identical amino acids
(dark shading) and conserved changes (lighter shading). Numbering
of the ERp29 sequence starts from the beginning of the mature pol-
ypeptide. PDI sequence numbering starts from the precursor’s ¢rst
amino acid. b, L-sheet; h, K-helix.
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binding. A similar oligomeric conformation is characteristic
also of some thioredoxin-like proteins with di¡erent functions,
such as glutathione S-transferase (dimer) and glutathione per-
oxidase (tetramer) [32]. Extensive interactions with diverse
protein substrates are vital not only for the thiol isomerase
activity of PDI but also for the general chaperone function,
that is for binding to and refolding the misfolded proteins.
The latter function is supported by the ¢nding that PDI may
fold proteins without internal disul¢de bonds [33,34] and also
by its integration in the prolyl hydroxylase [35] and triacyl-
glycerol transfer protein [36] complexes, where PDI does not
appear to have a redox activity, but instead has been sug-
gested to function as an internal folding factor stabilizing
the conformation of the complex.
Based on these observations we predict that ERp29, a di-
meric protein with a thioredoxin-like structure, which prob-
ably lost its redox activity in the course of evolution, may still
retain extensive protein-protein interacting features character-
istic of molecular chaperones or some related enzymes. It
seems that this assumption is consistent with other essential
traits of ERp29, such as stress inducibility, interaction with
BiP/GRP78, widespread expression and ER targeting. How-
ever, the purpose of the putative protein binding capabilities
of ERp29 still remains to be established as no characteristic
motifs, indicating possible function, such as active cysteine
sites are present in its sequence.
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